NEOGLIM-M1 Tablets
Composition
Each Uncoated Bi-layered Tablet Contains: - Glimepiride 1mg + Metformin 500mg in Prolonged Release form
Indication
Neoglim M1 is a highly effective combination of two antidiabetic medicines used in the treatment of type 2 diabetes mellitus in adults. This tablet contains Glimepiride 1mg and Metformin 500mg, working together to help manage blood sugar levels in diabetic patients.
Glimepiride, a sulfonylurea, increases insulin secretion from the pancreas, while Metformin, a biguanide, reduces glucose production in the liver, delays glucose absorption from the intestines, and improves the body’s sensitivity to insulin. Together, they form a powerful treatment duo that not only lowers blood glucose levels but also helps maintain them over time.
Maintaining optimal blood sugar levels with Neoglim M1 tablets is crucial to preventing serious complications of diabetes such as kidney damage, eye problems, nerve damage, and in extreme cases, amputation. This makes glimepiride and metformin hydrochloride prolonged release tablets IP a vital part of diabetes management for many adults.
The Neoglim M1 tablet is especially helpful when lifestyle changes and single-drug therapy aren't enough. It provides a comprehensive approach to glycemic control, enhancing quality of life and reducing long-term health risks.
If you're looking to include this treatment in your diabetes management plan, Neoglim M1 tablets are readily available through certified pharmacies. This medication offers a convenient and effective option for maintaining blood sugar control, suitable for both individual and clinical use. Always consult your healthcare provider before starting or adjusting any diabetes medication.
With Neoglim M1 tab, managing diabetes becomes less of a daily battle and more of a well-armed strategy.
Contraindication
Nausea, Diarrhoea, Headache, Upper respiratory tract infection, Dizziness, Flatulence
Storage
Cool & Dry Place
Dosage
As directed by a Medical Practitioner or Physician.
Inquire Now